FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087134411> ?p ?o ?g. }

• W2087134411 endingPage "540" @default.
• W2087134411 startingPage "525" @default.
• W2087134411 abstract "Neural carboxylesterases can be discriminated by differential inhibition assays with organophosphorus compounds (OPs), paraoxon (O,O'-diethyl p-nitrophenyl phosphate) and mipafox (N,N'-diisopropyl phosphorodiamidofluoridate) being the ones used to discriminate esterases that should be either irrelevant or candidates as targets of the mechanism of induction of the organophosphorus-induced delayed polyneuropathy (OPIDP). The brain membrane-bound phenyl valerate esterase (PVase) defined by Dr Johnson in 1969 as neuropathy target esterase (NTE) and recently cloned by Dr Glynn and coworkers is termed here as particulate NTE due to its association to the membrane particulate fraction. It is considered as the target of OPIDP and is the activity measured in standard NTE assays and toxicity tests. Following the same operational criteria in the soluble fraction of sciatic nerve a paraoxon-resistant but mipafox-sensitive PVase activity was described and termed as S-NTE, with an apparent lower sensitivity to some inhibitors than particulate NTE. Two isoforms (S-NTE1 and S-NTE2) were subsequently separated by gel filtration chromatography. In a partly purified S-NTE2 preparation polypeptides were identified in western blots by labelling with S9B [1-(saligenin cyclic phospho)-9-biotinyldiaminononane], the same biotinylated OP used to label and isolate particulate NTE, but not with anti-particulate NTE antibodies. From sequential inhibition protocols, inhibitor washing-out and time course inhibition studies it is deduced that reversibility of inhibition is a new factor introducing a higher complexity in the identification of the esterases that could be candidates as targets of the mechanisms of induction and/or promotion of neuropathy. We have evidences that in sciatic nerve soluble fraction a high proportion (about 70%) of the activity that is inhibited by paraoxon in the usual concurrent assay is quickly reactivated after removing paraoxon and it is permanently inhibited by mipafox. Under this improved sequential paraoxon/mipafox inhibition procedure S-NTE represents about 50% of total PVases while in the usual concurrent assay it was only apparently about 1-2%. Moreover with such criteria, S-NTE2 isoform(s) represents about 97-99% of total S-NTE, and S-NTE1 is only a marginal amount probably resulting of a partial solubilization from particulate NTE. Fixed time inhibiton curves with variable mipafox concentration failed to discriminate more than one component. However kinetic behaviour of the time progressive inhibition cannot be explained by a simple model with a single exponential mathematical component, indicating that either the possibility of more than one component or a more complex mechanistic model should be considered. Consequently both particulate NTE and S-NTE assay protocols and their role in induction and promotion of neuropathies will need to be reviewed. Data published by Drs Lotti, Moretto and coworkers suggest that particulate NTE cannot be the target of promotion of axonopathies. The proposal that S-NTE2 could be such a target is suggestive and under collaborative biochemical and toxicological studies." @default.
• W2087134411 created "2016-06-24" @default.
• W2087134411 creator A5048940337 @default.
• W2087134411 creator A5056030267 @default.
• W2087134411 creator A5068999361 @default.
• W2087134411 date "1999-05-01" @default.
• W2087134411 modified "2023-10-16" @default.
• W2087134411 title "NTE soluble isoforms: new perspectives for targets of neuropathy inducers and promoters" @default.
• W2087134411 cites W1773249187 @default.
• W2087134411 cites W1832902463 @default.
• W2087134411 cites W1854525516 @default.
• W2087134411 cites W1975250102 @default.
• W2087134411 cites W1983760243 @default.
• W2087134411 cites W1985900871 @default.
• W2087134411 cites W1987666189 @default.
• W2087134411 cites W1990339014 @default.
• W2087134411 cites W1994168503 @default.
• W2087134411 cites W2000298757 @default.
• W2087134411 cites W2007447534 @default.
• W2087134411 cites W2024411995 @default.
• W2087134411 cites W2025268842 @default.
• W2087134411 cites W2035401190 @default.
• W2087134411 cites W2039820557 @default.
• W2087134411 cites W2064599001 @default.
• W2087134411 cites W2090909706 @default.
• W2087134411 cites W2139607838 @default.
• W2087134411 cites W2216791376 @default.
• W2087134411 cites W324428513 @default.
• W2087134411 cites W44943491 @default.
• W2087134411 doi "https://doi.org/10.1016/s0009-2797(99)00067-8" @default.
• W2087134411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10421492" @default.
• W2087134411 hasPublicationYear "1999" @default.
• W2087134411 type Work @default.
• W2087134411 sameAs 2087134411 @default.
• W2087134411 citedByCount "15" @default.
• W2087134411 countsByYear W20871344112013 @default.
• W2087134411 countsByYear W20871344112014 @default.
• W2087134411 countsByYear W20871344112015 @default.
• W2087134411 countsByYear W20871344112016 @default.
• W2087134411 countsByYear W20871344112020 @default.
• W2087134411 crossrefType "journal-article" @default.
• W2087134411 hasAuthorship W2087134411A5048940337 @default.
• W2087134411 hasAuthorship W2087134411A5056030267 @default.
• W2087134411 hasAuthorship W2087134411A5068999361 @default.
• W2087134411 hasConcept C181199279 @default.
• W2087134411 hasConcept C185592680 @default.
• W2087134411 hasConcept C2777207434 @default.
• W2087134411 hasConcept C2778816929 @default.
• W2087134411 hasConcept C55493867 @default.
• W2087134411 hasConceptScore W2087134411C181199279 @default.
• W2087134411 hasConceptScore W2087134411C185592680 @default.
• W2087134411 hasConceptScore W2087134411C2777207434 @default.
• W2087134411 hasConceptScore W2087134411C2778816929 @default.
• W2087134411 hasConceptScore W2087134411C55493867 @default.
• W2087134411 hasLocation W20871344111 @default.
• W2087134411 hasLocation W20871344112 @default.
• W2087134411 hasOpenAccess W2087134411 @default.
• W2087134411 hasPrimaryLocation W20871344111 @default.
• W2087134411 hasRelatedWork W1991740491 @default.
• W2087134411 hasRelatedWork W2005222235 @default.
• W2087134411 hasRelatedWork W2009836746 @default.
• W2087134411 hasRelatedWork W2023533883 @default.
• W2087134411 hasRelatedWork W2052007642 @default.
• W2087134411 hasRelatedWork W2163945903 @default.
• W2087134411 hasRelatedWork W2373355100 @default.
• W2087134411 hasRelatedWork W2395149724 @default.
• W2087134411 hasRelatedWork W2521263407 @default.
• W2087134411 hasRelatedWork W61572660 @default.
• W2087134411 hasVolume "119-120" @default.
• W2087134411 isParatext "false" @default.
• W2087134411 isRetracted "false" @default.
• W2087134411 magId "2087134411" @default.
• W2087134411 workType "article" @default.